Yanbin Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yanbin Ma has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Liaoyuan A. Hu
Amgen Research, Amgen Biopharmaceutical R&D (Shanghai) Co., Ltd, Shanghai 201210, China
1 shared publication - Mei-Yun Zhang
Amgen Research, Amgen Asia R&D Center, Amgen Biopharmaceutical R&D (Shanghai) Co., Ltd., 13th Floor, Building No. 2, 4560 Jinke Road, Zhangjiang, Shanghai, 201210, China.
1 shared publication Ning Zhang
Amgen Discovery Research, Amgen Asia R&D Center, Amgen Biopharmaceutical R&D (Shanghai) Co. Ltd., 13th Floor, Building No. 2, 4560 Jinke Road, Zhangjiang, Shanghai 201210, China
1 shared publicationWenge Zhong
Amgen Discovery Research, Amgen Asia R&D Center, Amgen Biopharmaceutical R&D (Shanghai) Co. Ltd., 13th Floor, Building No. 2, 4560 Jinke Road, Zhangjiang, Shanghai 201210, China
1 shared publication- Xianqiang Song
Chinese Academy of Sciences
1 shared publication Xiaochuan Ma
Amgen Discovery Research, Amgen Asia R&D Center, Amgen Biopharmaceutical R&D (Shanghai) Co. Ltd., 13th Floor, Building No. 2, 4560 Jinke Road, Zhangjiang, Shanghai 201210, China
1 shared publication
Latest Publications
- Open Access
- 17 January 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (3) , eaax7379
Structure-guided discovery of a single-domain antibody agonist against human apelin receptor
We converted a potent antagonistic sdAb JN241 to an agonistic sdAb JN241-9 to human APJ by structure-guided rational design.
- 17 January 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (3) , eaax7379
Open AccessStructure-guided discovery of a single-domain antibody agonist against human apelin receptor
We converted a potent antagonistic sdAb JN241 to an agonistic sdAb JN241-9 to human APJ by structure-guided rational design.